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Cationic arene ruthenium metallaprisms of the general for-
mula [Ru6(p-cymene)6(tpt)2(OOOO)3]6+ {tpt = 2,4,6-tris(4-
pyridyl)-1,3,5-triazine; OOOO = 9,10-dioxo-9,10-dihydro-
anthracene-1,4-diolato [1]6+, 6,11-dioxo-6,11-dihydronaphth-
acene-5,12-diolato [2]6+} have been obtained from the cor-
responding dinuclear arene ruthenium complexes [Ru2(p-
cymene)2(OOOO)Cl2] by reaction with tpt and silver tri-
fluoromethanesulfonate. Aromatic molecules (phenanthrene,
pyrene, triphenylene, coronene) present during the synthesis
of these metallaprisms are permanently encapsulated to give
carceplex systems. All empty cages ([1]6+ and [2]6+) and car-
Introduction
The encapsulation of appropriately sized, shaped, and
functionalized guest molecules into self-assembling supra-
molecular capsules has received considerable attention, es-
pecially as a model for substrate recognition by enzymes.[1]
In the case of 3D coordination cages, a number of different
models have been reported in the literature over the past
few years. Nitrate encapsulation, both in the solid state and
in solution, by a cationic trigonal prismatic host has been
reported by Stang.[2] Entrapment of sizeable neutral mole-
cules, including o-carborane and adamantane, by a water-
soluble truncated tetrahedral capsule has been described by
Fujita.[3] The host property of these systems and of other
3D self-assembled aggregates has been largely demon-
strated[4] and potential uses are still in development.
Thus, in 2008, we reported the ability of hexacationic
metallaprism [Ru6(p-cymene)6(tpt)2(dobq)3]6+ [tpt = 2,4,6-
tri(pyridin-4-yl)-1,3,5-triazine; dobq = 3,6-dioxocyclohexa-
1,4-diene-1,4-diolato] to permanently encapsulate square-
planar complexes[5] and aromatic molecules.[6] Last year, the
facility to permanently encapsulate large planar molecules
as well as to allow host–guest chemistry to take place with
smaller aromatic molecules was demonstrated with a
slightly more spacious metallaprism: [Ru6(p-cymene)6(tpt)2-
(donq)3]6+ (donq = 5,8-dioxo-5,8-dihydronaphthalene-1,4-
diolato).[7]
[a] Institut de Chimie, Université de Neuchâtel, 51 Ave de Bellevaux, 2000 Neuchâtel, Switzerland Fax: +41-32-7182511
E-mail: bruno.therrien@unine.ch
ceplex systems ([guest1]6+ and [guest2]6+) were isolated
in good yield as trifluoromethanesulfonate salts and charac-
terized by NMR, UV, and IR spectroscopy. The host–guest
properties of [1]6+ and [2]6+ were studied in solution in the
presence of small aromatic molecules (phenanthrene and
pyrene). The stability constant of association (Ka) was
estimated by NMR spectroscopy for the following host–
guest systems: [phenanthrene1]6+, [pyrene1]6+ and
[phenanthrene2]6+, [pyrene2]6+. All Ka values were found
to be larger than 2.0104 M–1 for these host–guest systems
([D3]acetonitrile, 21 °C).
We have now extended these previous studies to two
others cationic hexanuclear metallaprisms: [Ru6(p-cymene)6-
(tpt)2(doaq)3]6+ ([1]6+; doaq = 9,10-dioxo-9,10-dihydro-
anthracene-1,4-diolato) and [Ru6(p-cymene)6(tpt)2(dotq)3]6+
([2]6+; dotq = 6,11-dioxo-6,11-dihydronaphthacene-5,12-di-
olato). Their aptitude to permanently encapsulate or to
temporary host aromatic molecules, according to the size
of the guest molecule, has been studied in solution, and the
corresponding binding constant of association for the host–
guest systems has been estimated.
Results and Discussion
Hexacationic metallaprisms 1 and 2 were synthesized by
following a one-step strategy. The corresponding dinuclear
arene ruthenium complex [Ru2(p-cymene)2(doaq)Cl2][8] or
[Ru2(p-cymene)2(dotq)Cl2][9] reacts in methanol at room
temperature in the presence of silver trifluoromethanesul-
fonate (halide scavenger) with tpt (donor ligand) to give the
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metallahexanuclear cation [1]6+ or [2]6+ isolated as the tri-
fluoromethanesulfonate salt in good yield (≈80 %,
Scheme 1). The addition of one equivalent of phenanthrene,
pyrene, triphenylene, or coronene leads to the direct encap-
sulation of the aromatic molecule in the metallaprism, fol-
lowing the same procedure but with a slightly better yield
(≈85%), possibly due to the template effect (Scheme 1).
The infrared spectra of 1 and 2 are dominated by absorp-
tions of the coordinated quinonato ligands, which are only
slightly shifted relative to those of the free ligands. In ad-
dition to these signals, strong absorptions due to the
stretching vibrations of the trifluoromethanesulfonate
anions [1260 (s), 1030 (s), 638 (m) cm–1] are also observed
in the infrared spectra of the salts [1][CF3SO3]6 and
[2][CF3SO3]6. In the cases of the [guest1]6+ and
[guest2]6+ systems, additional absorptions due to the
guest molecule are observed, and in particular a signal at
around 1500 cm–1 assigned to valence vibrations of aro-
matic Csp2–Csp2. The electronic absorption spectra of
metallaprisms 1 and 2 are characterized by an intense high-
energy band centered at around 320 nm, which is assigned
to a ligand-localized or intraligand π  π* transition as
well as broad low-energy bands associated to metal-to-
ligand charge transfer (MLCT) transitions.
The 1H NMR spectra of 1 and 2 show two doublets due
to the tpt protons with an upfield shift of the signals relative
to the signals of the free tpt molecule in [D6]acetone. Simi-
larly, the proton signals of the 9,10-dioxo-9,10-dihydro-
anthracene-1,4-diolato and 6,11-dioxo-6,11-dihydronaphth-
Scheme 1. Syntheses of [1]6+ and [2]6+ (top) and of [guest1]6+ and [guest2]6+ (bottom).
acene-5,12-diolato bridging ligands in metallaprisms 1 and
2 are shifted downfield relative to those of their parent
complexes [Ru2(p-cymene)2(doaq)Cl2] and [Ru2(p-cymene)2-
(dotq)Cl2],[8,9] whereas the methyl, isopropyl, and phenyl
signals of the p-cymene ligands remain almost unchanged.
To further study the structural behavior of cationic
metallaprisms 1 and 2 in solution, 1H NMR enantiodiffer-
entiation in [D6]acetone was achieved in the presence of the
NMR chiral solvating agent Λ-TRISPHAT [TRISPHAT =
tris(tetrachlorobenzenediolato)phosphate(V)].[10] Upon
gradual addition of Λ-TRISPHAT (0.1–5.0 equiv.) to a [D6]-
acetone solution of metallaprism 1 or 2, rapid and effective
splitting of all signals of the metallaprisms is observed (see
baseline-to-baseline separation of the p-cymene proton sig-
nals of 2 in Figure 1). This NMR enantiodifferentiation
confirms the expected helical chirality of metallaprisms 1
and 2, which was already observed for similar metalla-
assemblies.[11]
The formation of [guest1]6+ and [guest2]6+ can be
easily monitored by NMR spectroscopy. The signals of the
different protons of the guest molecule as well as those of
the pyridyl protons of the tpt panels are shifted upfield
upon formation of the host–guest system, whereas the sig-
nals of the CH protons of the doaq and dotq bridging li-
gands are shifted downfield. On the other hand, the signals
of the protons of the p-cymene ligands located at the pe-
riphery of the prisms are not significantly affected by the
presence of a guest molecule in the cavities of [1]6+ and
[2]6+ (Figure 2).
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Figure 1. Splitting of p-cymene proton signals of metallaprism
[2][CF3SO3]6 upon addition of Λ-TRISPHAT in [D6]acetone at
21 °C: (a) [2]6+ (4.0 m), (b) [2]6+ + Λ-TRISPHAT (2.0 equiv.), and
(c) [2]6+ + Λ-TRISPHAT (5.0 equiv.).
Figure 2. 1H NMR spectra (400 MHz, [D3]acetonitrile) of free
coronene (a), [coronene2][CF3SO3]6 (b), and [2][CF3SO3]6 (c).
1H ROESY experiments confirm the encapsulation of
aromatic molecules (phenanthrene, pyrene, triphenylene,
and coronene) in metallaprisms 1 and 2. For example, the
1H ROESY spectrum of [coronene2]6+ shows a strong nu-
clear Overhauser effect between the irradiated coronene and
tpt protons (Hα & Hβ). Moreover a weak nuclear Over-
hauser interaction with the protons of the quinonato brid-
ges (Hbq & Hcq) is as well observed (Figure 3).
Figure 3. 1D 1H ROESY spectrum (21 °C, [D3]acetonitrile) of
[coronene2]6+ (top). 1H NMR spectrum of [coronene2]-
[CF3SO3]6 (bottom).
To evaluate these metallacages as potential host–guest
systems, we first studied the stability of all systems in solu-
tion (water, toluene, acetonitrile) at room and elevated
temperatures. Complexes [triphenylene1]6+, [triphen-
ylene2]6+, [coronene1]6+, and [coronene2]6+ show no
degradation of the cages or leaching of the guests in all
solvents tested, even at reflux for 24 h. However, [phen-
anthrene1]6+, [phenanthrene2]6+, [pyrene1]6+, and
[pyrene2]6+ show rapid loss of their guest molecules in
[D8]toluene at 80 °C, whereas these systems remain intact
in acetonitrile and water. Therefore, we decided to further
study the host–guest chemistry of metallaprisms [1]6+ and
[2]6+ in acetonitrile solution by using NMR spectroscopy.
Upon gradual addition of guest (either phenanthrene or
pyrene, 0.1–3.0 equiv.) to a [D3]acetonitrile solution of the
metallaprism ([1][CF3SO3]6 or [2][CF3SO3]6, 4.0 m), the
1H NMR spectra show displacement of the chemical shifts
of the signals for some protons of the host and of the guest.
The broadening and chemical shifts of the signals clearly
support rapid inclusion of pyrene in the hydrophobic cavity
of [2]6+, as previously observed in analogous systems.[7] A
plot of these chemical shift changes (∆δ) for the Hβ proton
of the tpt ligands versus the molar ratio of pyrene/[2]6+ indi-
cates the stoichiometry of host–guest formation (Figure 4).
The plot shows unambiguously the formation of a 1:1 host–
guest system for which an association constant of
2.23104 –1 is calculated by the nonlinear least-square fit-
ting program winEQNMR2 (Table 1).[12]
Figure 4. 1H NMR chemical shift changes for the Hβ proton of the
tpt ligands vs. the molar ratio of pyrene/[2]6+ in [D3]acetonitrile at
21 °C.
Table 1. Association constants and free energies for the encapsul-
ation of phenanthrene and pyrene in [1]6+and [2]6+ ([D3]acetonitrile
at 21 °C, 4.0 m concentration of [1]6+ and [2]6+).
Complex Ka  104 –1 ∆G° (kcalmol–1)
[phenanthrene1]6+ 2.050.7 –5.880.2
[pyrene1]6+ 2.010.4 –5.870.1
[phenanthrene2]6+ 2.900.9 –6.080.2
[pyrene2]6+ 2.230.5 –5.930.6
Finally, DOSY measurements were performed to com-
plete the host–guest studies. This powerful tool for studying
host–guest association in solution is based on diffusion co-
efficients that depend on the shape and size of the mole-
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cules.[13] Thus, if the guest and the host keep their individ-
ual diffusion coefficients, there is no guesthost adduct.
However, if the guest is perfectly encapsulated in the cavity
of the host without significantly affecting the size and shape
of the host, the diffusion coefficient of the guesthost ad-
duct will be almost identical to the diffusion coefficient of
the host alone. DOSY spectra of [2]6+ and [phen-
anthrene2]6+ show diffusion coefficients that are almost
equivalent with values at around 5.610–10 m2 s–1, thus
confirming the encapsulation of phenanthrene in the hydro-
phobic cavity of [2]6+ and the formation of a [phen-
anthrene2]6+ adduct, without radical modification of the
shape of [2]6+ (Figure 5).
Figure 5. DOSY 1H NMR spectra of phenanthrene, [2]6+, and
[2]6+ + phenanthrene (1 equiv.) at 21 °C in [D3]acetonitrile.
Conclusions
We have described two new cationic metallaprisms with
different portal sizes that, in solution, are both able to allow
small aromatic molecules to enter and leave the hydro-
phobic cavity. However, for larger aromatic molecules cap-
able of fitting into the cavity but too large to exit the portal
of the cage, permanent encapsulation was observed, thus
giving rise to stable carceplex systems. Association con-
stants in all host–guest systems were found to be around
2.5104 –1, thus suggesting that the difference in the por-
tal size in those two metallaprisms does not affect the dy-
namic host–guest equilibrium in solution.
Experimental Section
General: [Ru2(p-cymene)2(doaq)Cl2],[8] [Ru2(p-cymene)2(dotq)-
Cl2],[9] and 2,4,6-tris(4-pyridyl)-1,3,5-triazine (tpt)[14] were prepared
according to published methods. Λ-TRISPHAT tetrabutylammo-
nium salt and all other reagents were commercially available
(Sigma–Aldrich) and used as received. 1H, 13C{1H}, 1H DOSY, and
1H ROESY NMR spectra were recorded with a Bruker AvanceII
400 spectrometer by using the residual protonated solvent as in-
ternal standard. Infrared spectra were recorded as KBr pellets with
a Perkin–Elmer FTIR 1720X spectrometer. UV/Vis absorption
spectra were recorded with a Uvikon 930 spectrometer by using
precision cells made of quartz (1 cm). Elemental analyses were per-
formed by the Laboratory of Pharmaceutical Chemistry, University
of Geneva (Switzerland).
Syntheses of [1][CF3SO3]6 and [2][CF3SO3]6: A mixture of [Ru2(p-
cymene)2(OOOO)Cl2] (OOOO = 9,10-dioxo-9,10-dihydro-
anthracene-1,4-diolato, 50.0 mg, 0.064 mmol; OOOO = 6,11-di-
oxo-6,11-dihydronaphthacene-5,12-diolato, 53.3 mg; 0.064 mmol),
AgCF3SO3 (33.0 mg, 0.128 mmol), and tpt (13.4 mg, 0.043 mmol)
in MeOH (20 mL) was heated under reflux for 24 h and then fil-
tered. The solvent was removed, and the dark residue was dissolved
in CH2Cl2 (3 mL). Diethyl ether was added to precipitate a dark
green solid. The solid was filtered and dried under vacuum.
[1][CF3SO3]6: Yield: 59 mg (76%). UV/Vis (1.010–5 , CH2Cl2):
λ (ε104, –1 cm–1) = 372 (4.3), 401 (4.0), 552 (1.3), 601 (1.9), 648
(2.2) nm. IR (KBr): ν˜ = 3065 (w, CHaryl), 1539 (s, C=O), 1261 (s,
CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.70 (m, 3 H, Hbq),
8.66 (m, 3 H, Hbq), 8.61 (dd, 3JH,H = 6.0 Hz, 6 H, Hα), 8.59 (dd, 6
H, Hα), 8.38 (dd, 3JH,H = 5.8 Hz, 6 H, Hβ), 8.35 (dd, 6 H, Hβ),
7.99 (m, 3 H, Hcq), 7.95 (m, 3 H, Hcq), 7.27 (d, 3JH,H = 4.1 Hz, 3
H, Haq), 7.23 (d, 3 H, Haq), 5.81 (m, 6 H, Hcym), 5.75 (m, 6 H,
Hcym), 5.58 (m, 12 H, Hcym), 2.89 [sept, 3JH,H = 6.7 Hz, 6 H,
CH(CH3)2], 2.12 (m, 18 H, CH3), 1.31 [m, 36 H, CH(CH3)2] ppm.
13C{1H} NMR (100 MHz, CD3CN): δ = 171.5 (CO), 170.6 (Ctpt),
170.5 (CO), 154.2 (CHα), 145.1 (Ctpt), 138.7 (CHaq), 134.4 (CHcq),
134.0 (Cq), 128.3 (CHbq), 124.9 (CHβ), 110.7 (Cq), 104.8 (Ccym),
100.6 (Ccym), 85.3 (CHcym), 85.0 (CHcym), 83.9 (CHcym), 83.8
(CHcym), 31.4 [CH(CH3)2], 22.5 [CH(CH3)2], 22.3 [CH(CH3)2], 17.6
(CH3) ppm. C144H126F18N12O30Ru6S6 (3645.5): calcd. C 47.44, H
3.48, N 4.61; found C 47.51, H 3.60, N 4.63.
[2][CF3SO3]6: Yield: 62 mg (77%). UV/Vis (1.010–5 , CH2Cl2):
λ (ε104, –1 cm–1) = 370 (4.2), 398 (3.4), 558 (1.0), 602 (1.9), 650
(2.0) nm. IR (KBr): ν˜ = 3070 (w, CHaryl), 1540 (s, C=O), 1260 (s,
CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.74 (br., 12 H,
Hbq), 8.62 (br., 12 H, Hα), 8.27 (br., 12 H, Hβ), 7.97 (br., 12 H,
Hcq), 5.88 (d, 3JH,H = 6.3 Hz, 12 H, Hcym), 5.66 (d, 12 H, Hcym),
2.93 [sept, 3JH,H = 6.9 Hz, 6 H, CH(CH3)2], 2.13 (s, 18 H, CH3),
1.30 [d, 36 H, CH(CH3)2] ppm. 13C{1H} NMR (100 MHz,
CD3CN): δ = 170.5 (Ctpt), 170.0 (CO), 154.1 (CHα), 145.0 (Ctpt),
134.6 (Cq), 134.1 (CHcq), 128.2 (CHbq), 124.9 (CHβ), 108.1 (Cq),
104.9 (Ccym), 100.7 (Ccym), 85.1 (CHcym), 83.6 (CHcym), 31.5
[CH(CH3)2], 22.5 [CH(CH3)2], 17.8 (CH3) ppm.
C156H132F18N12O30Ru6S6 (3795.6): calcd. C 49.36, H 3.51, N 4.43;
found C 49.88, H 3.70, N 4.44.
Syntheses of [Guest1][CF3SO3]6 and [Guest2][CF3SO3]6: To a
mixture of [Ru2(p-cymene)2(OOOO)Cl2] (OOOO = 9,10-dioxo-
9,10-dihydroanthracene-1,4-diolato, 50.0 mg, 0.064 mmol;
OOOO = 6,11-dioxo-6,11-dihydronaphthacene-5,12-diolato,
53.3 mg, 0.064 mmol) and AgCF3SO3 (33.0 mg, 0.128 mmol) in
MeOH (20 mL) was added tpt (13.4 mg, 0.043 mmol) and the aro-
matic guest molecule (phenanthrene 4.1 mg, 0.023 mmol; pyrene
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4.7 mg, 0.023 mmol; triphenylene 5.3 mg, 0.023 mmol; coronene
6.9 mg, 0.023 mmol). The mixture was stirred at reflux for 24 h and
then filtered. The solvent was removed, and the dark residue was
dissolved in CH2Cl2 (3 mL). Diethyl ether was added to precipitate
a dark green solid. The solid was filtered and dried under vacuum.
[Phenanthrene1][CF3SO3]6: Yield: 68 mg (84%). UV/Vis
(1.010–5 , CH2Cl2): λ (ε104, –1 cm–1) = 373 (4.0), 399 (3.8),
554 (1.3), 601 (1.8), 648 (2.1) nm. IR (KBr): ν˜ = 3068 (w, CHaryl),
1539 (s, C=O), 1262 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN):
δ = 8.74 (m, 3 H, Hbq), 8.70 (m, 3 H, Hbq), 8.56 (dd, 3JH,H =
6.3 Hz, 6 H, Hα), 8.53 (dd, 6 H, Hα), 8.19 (m, 12 H, Hβ), 8.02 (m,
6 H, Hcq), 7.41 (m, 2 H, Hphenanthrene), 7.33 (d, 3JH,H = 3.7 Hz, 3
H, Haq), 7.29 (d, 3 H, Haq), 6.91 (d, 3JH,H = 7.7 Hz, 2 H,
Hphenanthrene), 5.81 (m, 6 H, Hcym), 5.75 (m, 6 H, Hcym), 5.63 (m, 2
H, Hphenanthrene), 5.57 (m, 12 H, Hcym), 5.20 (m, 2 H, Hphenanthrene),
4.50 (dd, 2 H, Hphenanthrene), 2.89 [sept, 3JH,H = 6.5 Hz, 6 H,
CH(CH3)2], 2.11 (m, 18 H, CH3), 1.32 [m, 36 H, CH(CH3)2] ppm.
13C{1H} NMR (100 MHz, CD3CN): δ = 171.5 (CO), 170.6 (CO),
170.3 (Ctpt), 154.0 (CHα), 145.0 (Ctpt), 138.8 (CHaq), 134.5 (CHcq),
134.1 (Cq), 128.4 (CHbq), 124.8 (CHβ), 110.6 (Cq), 104.8 (Ccym),
100.7 (Ccym), 85.3 (CHcym), 85.0 (CHcym), 83.9 (CHcym), 83.8
(CHcym), 31.5 [CH(CH3)2], 22.5 [CH(CH3)2], 22.3 [CH(CH3)2], 17.6
(CH3) ppm. C158H136F18N12O30Ru6S6 (3823.7): calcd. C 49.63, H
3.59, N 4.40; found C 49.77, H 3.72, N 4.45.
[Pyrene1][CF3SO3]6: Yield: 68 mg (83%). UV/Vis (1.010–5 ,
CH2Cl2): λ (ε104, –1 cm–1) = 321 (7.1), 337 (6.9), 374 (4.3), 402
(4.1), 554 (1.3), 601 (1.9), 649 (2.3) nm. IR (KBr): ν˜ = 3064 (w,
CHaryl), 1539 (s, C=O), 1260 (s, CF3) cm–1. 1H NMR (400 MHz,
CD3CN): δ = 8.79 (m, 6 H, Hbq), 8.48 (m, 12 H, Hα), 8.10 (m, 6
H, Hcq), 7.95 (m, 12 H, Hβ), 7.42 (m, 6 H, Haq), 6.16 (m, 4 H,
Hpyrene), 5.81 (m, 6 H, Hcym), 5.75 (m, 6 H, Hcym), 5.65 (br., 2 H,
Hpyrene), 5.56 (m, 12 H, Hcym), 5.00 (m, 4 H, Hpyrene), 2.89 [sept,
3JH,H = 6.7 Hz, 6 H, CH(CH3)2], 2.09 (m, 18 H, CH3), 1.32 [m, 36
H, CH(CH3)2] ppm. 13C{1H} NMR (100 MHz, CD3CN): δ = 171.5
(CO), 170.7 (CO), 169.9 (Ctpt), 153.7 (CHα), 144.3 (Ctpt), 139.0
(CHaq), 134.7 (CHcq), 134.2 (Cq), 129.9 (CHpyrene), 128.4 (CHbq),
127.1 (CHpyrene), 125.1 (CHpyrene), 124.5 (CHβ), 110.7 (Cq), 104.8
(Ccym), 100.7 (Ccym), 85.7 (CHcym), 85.2 (CHcym), 83.8 (CHcym),
83.1 (CHcym), 31.4 [CH(CH3)2], 22.4 [CH(CH3)2], 17.6 (CH3) ppm.
C160H136F18N12O30Ru6S6 (3847.7): calcd. C 49.95, H 3.56, N 4.37;
found C 49.98, H 3.74, N 4.42.
[Triphenylene1][CF3SO3]6: Yield: 72 mg (84%). UV/Vis
(1.010–5 , CH2Cl2): λ (ε104, –1 cm–1) = 380 (3.8), 415 (4.0),
550 (0.9), 612 (1.5), 659 (1.9) nm. IR (KBr): ν˜ = 3060 (w, CHaryl),
1539 (s, C=O), 1260 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN):
δ = 8.82 (m, 6 H, Hbq), 8.38 (dd, 3JH,H = 6.3 Hz, 6 H, Hα), 8.29
(dd, 6 H, Hα), 8.28 (m, 6 H, Hcq), 7.71 (br., 3 H, Haq), 7.69 (d,
3JH,H = 2.5 Hz, 3 H, Haq), 6.92 (dd, 3JH,H = 6.6 Hz, 6 H, Hβ), 6.79
(dd, 6 H, Hβ), 6.58 (m, 6 H, Htriphenylene), 5.78 (m, 6 H, Hcym), 5.74
(m, 6 H, Hcym), 5.63 (m, 12 H, Hcym), 4.44 (m, 6 H, Htriphenylene),
2.88 [sept, 3JH,H = 6.4 Hz, 6 H, CH(CH3)2], 2.04 (m, 18 H, CH3),
1.29 [m, 36 H, CH(CH3)2] ppm. 13C{1H} NMR (100 MHz,
CD3CN): δ = 171.3 (CO), 171.1 (CO), 166.0 (Ctpt), 152.0 (CHα),
142.4 (Ctpt), 138.5 (CHaq), 134.6 (CHcq), 132.2 (Cq), 128.4
(Ctriphenylene), 128.1 (CHbq), 127.1 (CHtriphenylene), 122.4
(CHtriphenylene), 120.2 (CHβ), 108.9 (Cq), 103.2 (Ccym), 100.1 (Ccym),
86.4 (CHcym), 86.1 (CHcym), 83.0 (CHcym), 82.9 (CHcym), 30.4
[CH(CH3)2], 21.6 [CH(CH3)2], 21.4 [CH(CH3)2], 16.9 (CH3) ppm.
C162H138F18N12O30Ru6S6 (3873.8): calcd. C 50.23, H 3.59, N 4.34;
found C 50.45, H 3.73, N 4.43.
[Coronene1][CF3SO3]6: Yield: 72 mg (86%). UV/Vis (1.010–5 ,
CH2Cl2): λ (ε104, –1 cm–1) = 385 (3.9), 409 (3.9), 555 (0.8), 609
(1.5), 654 (1.8) nm. IR (KBr): ν˜ = 3062 (w, CHaryl), 1539 (s, C=O),
1261 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.95 (m, 6
H, Hbq), 8.35 (dd, 3JH,H = 6.4 Hz, 6 H, Hα), 8.30 (dd, 6 H, Hα),
8.29 (m, 6 H, Hcq), 7.70 (br., 3 H, Haq), 7.67 (d, 3JH,H = 2.4 Hz, 3
H, Haq), 6.86 (dd, 3JH,H = 6.4 Hz, 6 H, Hβ), 6.77 (dd, 6 H, Hβ),
6.59 (s, 12 H, Hcoronene), 5.80 (m, 6 H, Hcym), 5.71 (m, 6 H, Hcym),
5.53 (m, 12 H, Hcym), 2.88 [sept, 3JH,H = 6.4 Hz, 6 H, CH-
(CH3)2], 2.05 (m, 18 H, CH3), 1.31 [m, 36 H, CH(CH3)2] ppm.
13C{1H} NMR (100 MHz, CD3CN): δ = 170.2 (CO), 170.1 (CO),
166.1 (Ctpt), 152.2 (CHα), 142.0 (Ctpt), 138.4 (CHaq), 134.1 (CHcq),
133.3 (Cq), 127.8 (CHbq), 127.2 (Ccoronene), 125.2 (CHcoronene), 122.6
(CHβ), 120.4 (Ccoronene), 109.7 (Cq), 103.9 (Ccym), 99.8 (Ccym), 84.5
(CHcym), 84.1 (CHcym), 83.0 (CHcym), 82.9 (CHcym), 30.6 [CH-
(CH3)2], 21.6 [CH(CH3)2], 21.4 [CH(CH3)2], 16.7 (CH3) ppm.
C168H138F18N12O30Ru6S6 (3945.8): calcd. C 51.09, H 3.62, N 4.25;
found C 51.14, H 3.53, N 4.26.
[Phenanthrene2][CF3SO3]6: Yield: 70 mg (83 %). UV/Vis
(1.010–5 , CH2Cl2): λ (ε104, –1 cm–1) = 354 (6.3), 368 (6.2),
523 (1.7), 563 (2.7), 607 (3.4) nm. IR (KBr): ν˜ = 3070 (w, CHaryl),
1544 (s, C=O), 1259 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN):
δ = 8.78 (dd, 3JH,H = 6.0 Hz, 4JH,H = 3.4 Hz, 12 H, Hbq), 8.54 (d,
3JH,H = 6.4 Hz, 12 H, Hα), 8.01 (m, 24 H, Hβ and Hcq), 6.73 (br.,
2 H, Hphenanthrene), 5.87 (d, 3JH,H = 6.3 Hz, 12 H, Hcym), 5.75 (br.,
2 H, Hphenanthrene), 5.63 (d, 12 H, Hcym), 5.56 (br., 2 H,
Hphenanthrene), 5.16 (br., 2 H, Hphenanthrene), 4.63 (br., 2 H,
Hphenanthrene), 2.93 [sept, 3JH,H = 6.9 Hz, 6 H, CH(CH3)2], 2.11 (s,
18 H, CH3), 1.30 [d, 36 H, CH(CH3)2] ppm. 13C{1H} NMR
(100 MHz, CD3CN): δ = 168.7 (CO), 166.2 (Ctpt), 152.5 (CHα),
141.0 (Ctpt), 133.3 (Cq), 132.9 (CHcq), 127.0 (CHbq), 123.4 (CHβ),
106.7 (Cq), 103.5 (Ccym), 99.4 (Ccym), 83.9 (CHcym), 82.3 (CHcym),
30.1 [CH(CH3)2], 21.2 [CH(CH3)2] 16.5 (CH3) ppm.
C170H142F18N12O30Ru6S6 (3973.8): calcd. C 51.33, H 3.70, N 4.22;
found C 51.38, H 3.60, N 4.23.
[Pyrene2][CF3SO3]6: Yield: 75 mg (84%). UV/Vis (1.010–5 ,
CH2Cl2): λ (ε104, –1 cm–1) = 350 (6.1), 362 (6.2), 522 (1.6), 565
(2.6), 609 (3.6) nm. IR (KBr): ν˜ = 3070 (w, CHaryl), 1540 (s, C=O),
1260 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.80 (dd,
3JH,H = 6.3 Hz, 4JH,H = 3.2 Hz, 12 H, Hbq), 8.50 (d, 3JH,H = 6.5 Hz,
12 H, Hα), 8.01 (m, 24 H, Hβ and Hcq), 6.14 (m, 4 H, Hpyrene), 5.90
(d, 3JH,H = 6.2 Hz, 12 H, Hcym), 5.70 (br., 2 H, Hpyrene), 5.60 (d,
12 H, Hcym), 5.05 (m, 4 H, Hpyrene), 2.94 [sept, 3JH,H = 6.9 Hz, 6
H, CH(CH3)2], 2.10 (s, 18 H, CH3), 1.29 [d, 36 H, CH(CH3)2] ppm.
13C{1H} NMR (100 MHz, CD3CN): δ = 170.1 (CO), 165.8 (Ctpt),
152.4 (CHα), 141.2 (Ctpt), 133.1 (Cq), 132.6 (CHcq), 129.7
(CHpyrene), 127.4 (CHpyrene), 127.0 (CHbq), 125.3 (CHpyrene), 123.0
(CHβ), 106.8 (Cq), 103.4 (Ccym), 99.2 (Ccym), 83.6 (CHcym), 82.1
(CHcym), 29.9 [CH(CH3)2], 19.2 [CH(CH3)2] 16.8 (CH3) ppm.
C172H142F18N12O30Ru6S6 (3997.8): calcd. C 51.67, H 3.68, N 4.20;
found C 51.96, H 3.90, N 4.28.
[Triphenylene2][CF3SO3]6: Yield: 75 mg (87 %). UV/Vis
(1.010–5 , CH2Cl2): λ (ε104, –1 cm–1) = 351 (6.3), 368 (6.1),
526 (1.5), 564 (2.5), 608 (3.3) nm. IR (KBr): ν˜ = 3069 (w, CHaryl),
1543 (s, C=O), 1259 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN):
δ = 8.86 (m, 12 H, Hbq), 8.42 (d, 3JH,H = 5.7 Hz, 12 H, Hα), 8.12
(m, 12 H, Hcq), 7.58 (d, 12 H, Hβ), 6.58 (m, 6 H, Htriphenylene), 5.87
(d, 3JH,H = 5.9 Hz, 12 H, Hcym), 5.61 (d, 12 H, Hcym), 4.41 (m, 6
H, Htriphenylene), 2.92 [sept, 3JH,H = 6.9 Hz, 6 H, CH(CH3)2], 2.06
(s, 18 H, CH3), 1.29 [d, 36 H, CH(CH3)2] ppm. 13C{1H} NMR
(100 MHz, CD3CN): δ = 170.2 (CO), 168.6 (Ctpt), 153.0 (CHα),
143.9 (Ctpt), 134.6 (CHcq), 134.4 (Cq), 128.5 (Ctriphenylene), 128.5
(CHbq), 126.4 (CHtriphenylene), 124.4 (CHβ), 122.9 (CHtriphenylene),
107.8 (Cq), 104.8 (Ccym), 100.8 (Ccym), 85.3 (CHcym), 83.5 (CHcym),
5
31.5 [CH(CH3)2], 22.5 [CH(CH3)2], 17.8 (CH3) ppm.
C174H144F18N12O30Ru6S6 (4023.9): calcd. C 51.94, H 3.61, N 4.23;
found C 51.92, H 3.71, N 4.18.
[Coronene2][CF3SO3]6: Yield: 71 mg (81%). UV/Vis (1.010–5 ,
CH2Cl2): λ (ε104, –1 cm–1) = 305 (17.2), 343 (8.7), 372 (5.8), 568
(2.3), 611 (3.0) nm. IR (KBr): ν˜ = 3064 (w, CHaryl), 1544 (s, C=O),
1261 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.99 (dd,
3JH,H = 5.9 Hz, 4JH,H = 3.4 Hz, 12 H, Hbq), 8.36 (d, 3JH,H = 6.5 Hz,
12 H, Hα), 8.27 (dd, 12 H, Hcq), 6.71 (d, 12 H, Hβ), 6.23 (s, 12 H,
Hcoronene), 5.86 (d, 3JH,H = 6.1 Hz, 12 H, Hcym), 5.60 (d, 12 H,
Hcym), 2.93 [sept, 3JH,H = 6.9 Hz, 6 H, CH(CH3)2], 2.05 (s, 18 H,
CH3), 1.31 [d, 36 H, CH(CH3)2] ppm. 13C{1H} NMR (100 MHz,
CD3CN): δ = 169.9 (CO), 166.0 (Ctpt), 152.1 (CHα), 141.8 (Ctpt),
133.9 (Cq), 133.8 (CHcq), 127.7 (CHbq), 127.0 (Ccoronene), 124.9
(CHcoronene), 122.5 (CHβ), 120.2 (Ccoronene), 107.1 (Cq), 104.0
(Ccym), 99.8 (Ccym), 84.2 (CHcym), 82.7 (CHcym), 30.6 [CH(CH3)2],
21.6 [CH(CH3)2], 16.9 (CH3) ppm. C180H144F18N12O30Ru6S6
(4095.9): calcd. C 52.78, H 3.54, N 4.10; found C 52.91, H 3.72, N
4.12.
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